Gut bacteria balance may mark MS in people and mice

Credibility

Interest

Share:1 min read

Key Takeaway

People with MS had a different balance of two gut bacteria than people without MS.

What They Found

Researchers compared stool samples from people with MS and people without MS. The groups had different mixes of gut bacteria. A lower balance of one gut bacterium compared with another also appeared in people with MS in a separate study. Mice with an MS-like disease showed the same lower balance. In mice given a different gut bacterium, that balance was lower before disease began and was linked to worse disease later.

Who Should Care and Why

The researchers studied people with and without MS, as well as mice with an MS-like disease. The human findings concern differences in gut bacteria, not whether those bacteria cause MS. The mouse findings add evidence that this balance is linked to disease severity. Researchers also gave mice one type of gut bacterium and found more signs of gut inflammation. These findings may help researchers study whether gut bacteria can serve as a marker for MS.

Important Considerations

You cannot tell from this study whether a gut bacteria test can diagnose or predict MS. The abstract does not give the number of people studied. The mouse experiments do not show that changing gut bacteria would help people with MS.

AI-generated summary — for informational purposes only, not medical advice

Categories:

Early Research MS Diagnostics

Article Topics:

gut microbial markersgut microbiomeinflammationmicrobial ratiomultiple sclerosis

Whether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Proceedings of the National Academy of Sciences of the United States of America often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.

However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.

By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.

Back to News